BBIO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - BridgeBio Pharma Inc

Watchlist Manager

Watchlist

Price: 84.02 USD 1.31% Market Closed

Market Cap: $16.5B

	BridgeBio Pharma Inc NASDAQ:BBIO	US
	SKY Perfect JSAT Holdings Inc F:SKM	JP
	Bakrie & Brothers Tbk PT F:LFU2	ID
O	Orezone Gold Corp TSX:ORE	CA
	DREAM Unlimited Corp F:50DA	CA
	Andritz AG OTC:ADRZF	AT
S	Sixt SE XMUN:SIX3	DE
B	Boise Cascade Co F:BC0	US
V	Verisign Inc DUS:VRS	US
	Exail Technologies PAR:EXA	FR
	Semiconductor Manufacturing International Corp SSE:688981	CN

Profitability Summary

BridgeBio Pharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

89%

Gross Margin is Increasing

54% > 95%

Negative Operating Margin

-87%

Negative 3Y Average Operating Margin

-1 944%

Operating Margin is Increasing

-8 996% > -87%

Negative Net Margin

-124%

Negative 3Y Average Net Margin

-2 145%

Net Margin is Increasing

-10 088% > -124%

Negative Free Cash Flow Margin

-78%

Negative 3Y Average Free Cash Flow Margin

-1 791%

Free Cash Flow Margin is Increasing

-8 593% > -78%

Exceptional ROE

37%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-277%

ROIC is Increasing

-403% > -141%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.